Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat PCDHB5 ELISA Kit (AC3661)
Cat.#: ASET-2250
Specifications
Description Rat PCDHB5 ELISA Kit allows for the in vitro quantitative determination of rat PCDHB5 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1865 Rat Mu Opioid Receptor ELISA Kit (AC3276) Quantitative inquiry ASET-1175 Human CLN3 ELISA Kit (AC2586) Quantitative inquiry ASET-2221 Mouse VEGFB ELISA Kit (AC3632) Quantitative inquiry ASET-2237 Human ATG3 ELISA Kit (AC3648) Quantitative inquiry ASET-1442 Porcine Leptin ELISA Kit (AC2853) Quantitative inquiry ASET-1110 Mouse ABCA1 ELISA Kit (AC2521) Quantitative inquiry ASET-1995 Human NRG4 ELISA Kit (AC3406) Quantitative inquiry ASET-1898 Monkey beta Nerve Growth Factor ELISA Kit (AC3309) Quantitative inquiry ASET-1795 Guinea Pig beta Nerve Growth Factor ELISA Kit (AC3206) Quantitative inquiry ASET-2127 Human NDRG1 ELISA Kit (AC3538) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket